#immunotherapy

Genomic profiling showed patients with African ancestry had fewer actionable mutations and were less likely to qualify for immunotherapy.

Moderna and Merck’s personalized neoantigen vaccine plus checkpoint inhibitor lowered the risk of disease progression after surgery by 44%.

Antonio Jimeno, MD, PhD, led research studying a cell squeezing process used to treat a subtype of HPV16-driven head and neck cancer.

Treatment can improve quality of life for people with advanced breast cancer.

Clinical trials are scientific studies of experimental treatments. Here’s how to find one that might be right for you.

Dana-Farber researchers explore CAR-T therapy and next generation immunotherapy to target colorectal cancer.

Balyn Zaro, PhD, studies genetic differences in the innate immune system and how they can impact the effectiveness of the meds we take.

Immunotherapy drug Blincyto extends life for those with acute lymphoblastic leukemia (ALL) in remission

Immunotherapy leads the way, along with promising breakthroughs for treating leukemia and multiple myeloma.

For people who are newly diagnosed or undergoing active treatment, there is little specific dietary guidance, but new evidence is emerging.

Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.

Many cancer patients eligible for CAR-T therapy must live away from home for several months while they complete treatment.

Can a person’s immune system help prevent two types of non-small-cell lung cancer? Here’s how Robert Keith, MD, hopes to find out.

A new report tracks the most prominent cancers for men and women and finds substantial racial disparities in cancer treatment.

Microorganisms in the gut influence how the body responds to common cancer treatments, including immunotherapy.

Compared with men, women had a 34% greater likelihood of adverse events, especially if they received immunotherapy.